Cargando…

13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up

Background: A specific, cost-effective triage test for minor cytological abnormalities is essential for cervical cancer screening among younger women to reduce overmanagement and unnecessary healthcare utilization. We compared the triage performance of one 13-type human papillomavirus (HPV) DNA test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rad, Amir, Sørbye, Sveinung Wergeland, Brenn, Tormod, Tiwari, Sweta, Løchen, Maja-Lisa, Skjeldestad, Finn Egil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002392/ https://www.ncbi.nlm.nih.gov/pubmed/36901129 http://dx.doi.org/10.3390/ijerph20054119

Ejemplares similares

5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions
por: Westre, Bjørn, et al.
Publicado: (2016)

Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
por: Rad, Amir, et al.
Publicado: (2023)

HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2014)

Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women—A cohort study
por: Westre, Bjørn, et al.
Publicado: (2019)

HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests
por: Rad, Amir, et al.
Publicado: (2017)

May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
por: Skjeldestad, Finn Egil, et al.
Publicado: (2023)

Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2016)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)

HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
por: Asciutto, Katrin Christine, et al.
Publicado: (2020)

Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
por: Al-Shibli, Khalid, et al.
Publicado: (2022)

Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study
por: Riibe, Marit Østlyngen, et al.
Publicado: (2021)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Two Years of Cytology and HPV Co-Testing in Germany: Initial Experience
por: Xhaja, Arjola, et al.
Publicado: (2022)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study
por: Persson, Maria, et al.
Publicado: (2014)

Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study
por: Gilbert, Laura, et al.
Publicado: (2022)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
por: Kotaniemi-Talonen, L, et al.
Publicado: (2005)

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study
por: Kelly, R S, et al.
Publicado: (2011)

Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study
por: Hanley, Sharon J.B., et al.
Publicado: (2021)

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
por: Arbyn, Marc, et al.
Publicado: (2009)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

Performance of HPV16/18 in Triage of Cytological Atypical Squamous Cells of Undetermined Significance
por: Cao, Xiaoqin, et al.
Publicado: (2019)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women
por: Benski, Anne-Caroline, et al.
Publicado: (2019)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test
por: Wang, Ling, et al.
Publicado: (2022)

The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
por: Song, Fangbin, et al.
Publicado: (2020)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

DNA methylation testing with S5 for triage of high‐risk HPV positive women
por: Adcock, Rachael, et al.
Publicado: (2022)

Molecular triaging options for women testing HPV positive with self-collected samples
por: Taghavi, Katayoun, et al.
Publicado: (2023)

Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2023)

Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
por: Bergeron, Christine, et al.
Publicado: (2015)

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
por: Tantitamit, Tanitra, et al.
Publicado: (2020)

Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women
por: Hermansson, Ruth S., et al.
Publicado: (2022)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fn0u92hl85ikegt57ub3rb0ugn